Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000532309 | SCV000645601 | likely benign | PTEN hamartoma tumor syndrome | 2022-08-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000584148 | SCV000691176 | likely benign | Hereditary cancer-predisposing syndrome | 2016-02-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000584148 | SCV001186656 | likely benign | Hereditary cancer-predisposing syndrome | 2019-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000532309 | SCV004838566 | likely benign | PTEN hamartoma tumor syndrome | 2024-04-16 | criteria provided, single submitter | clinical testing |